Patients weren’t warned of serious bleeding risk
UPDATE: RPWB is no longer taking new clients for the litigation.
The blood thinner Xarelto causes uncontrolled bleeding in some patients who took the drug to prevent blood clots following surgical procedures or to minimize the risk of strokes due to atrial fibrillation. Because there is no antidote to the bleeding, it can have profound health effects on patients and is even known to cause death.
We wanted to take a moment to bring you up to speed on the case against Xarelto. If you or someone close to you has experienced uncontrolled bleeding or hemorrhagic stroke after taking Xarelto, we believe it is important for you to understand your legal rights. Our firm represents people nationwide who have been injured as a result of taking Xarelto. Please contact us if we can be of assistance.
The warnings given to patients and physicians are insufficient. This particular class of anticoagulants can cause severe injury or even death if the bleeding is not able to be controlled. Unlike some other anticoagulants, there is not currently an antidote for the severe bleeding.
Xarelto was approved in July 2011 for use in patients to reduce the risk of deep vein thrombosis and pulmonary embolism following joint replacement surgery. Several months later, it was approved for use by people suffering from atrial fibrillation (irregular heart rate). At the same time, the label warnings were updated to include an increased risk of bleeding.
In October 2017, Bayer pulled the plug on a study after lackluster results were beginning to show that the drug was no more effective in preventing strokes than a common over-the-counter drug. In the study, Xarelto did not prevent strokes as well as low doses of aspirin. Those who used Xarelto suffered more uncontrolled bleeding events than aspirin users.
Litigation against a similar drug, Pradaxa, was settled in May 2014 for $650 million. The watchdog group, Institute for Safe Medicines Practices, issued a report in 2013 stating that more patients have suffered serious adverse events from Xarelto than with Pradaxa.
Xarelto was developed by Bayer and marketed in the United States by Janssen Pharmaceuticals, a division of Johnson & Johnson. Annual sales in the United States were expected to top $1 billion dollars last year. Xarelto is the cornerstone of Bayer’s pharmaceutical business. The manufacturers are actively seeking to broaden its usage to also include acute coronary syndrome. The company has predicted the drug’s sales will eventually top $3.5 billion a year.
We believe it is important for people who suffered from uncontrolled bleeding after taking Xarelto to file suit. Not only should they be fully compensated for their injuries, but doing so also will push the manufacturer to improve the information it provides consumers and physicians. This will enable people to make an informed choice about whether they want to use Xarelto.
In late 2014, the thousands of Xarelto cases filed in federal courts throughout the country were consolidated in the Eastern District of Louisiana in front of Judge Eldon E. Fallon. Four initial bellwether trials were held through the end of 2017. The first trial began the week of April 24, and concluded with a defense verdict in early May. The second Xarelto trial began on May 30, and ended with a defense verdict on June 13. It was followed by another defense verdict in the third trial. In November 2017, the litigation shifted to state court in Philadephia, where more than 1,500 Xarelto cases are pending, and the jury returned a $29 million verdict on behalf of a woman who suffered from gastrointestinal bleeding from taking Xarelto. That award was later reversed on appeal.
On February 27, 2018, Judge Fallon released a new case management order that called for the 1,200 Xarelto cases to be prepared for trial. Those cases will be selected in April and August. Discovery for the first wave of 600 cases is scheduled to be completed by late 2018 or early 2019.
The individual characteristics of each case are different, so we urge patience as the process unfolds. As of May 2017, there were reported to be more than 18,000 Xarelto lawsuits filed in federal and state court.
If you or a loved one experienced uncontrolled bleeding as a result of taking Xarelto, the time is right to file suit. Statutes of limitation may impact the amount of time you have to file a lawsuit. Please contact us so we can answer specific questions about your case and the legal process for obtaining compensation for your injuries.
RPWB represents people throughout the country who were injured as a result of taking Xarelto. Unlike some of the other websites you may have clicked on, we are not a legal lead generation service. We are real lawyers who will handle your case. Our firm is well-known for its work in helping those who have been harmed by pharmaceutical drugs and medical devices. We are a 2018 U.S. News & World Report Best Law Firm. Our pharmaceutical team has been appointed lead counsel in seven large multi-district litigations and leadership positions in many more.
Our attorneys are sensitive to the wishes of our clients yet tenacious and experienced enough to secure the compensation our clients need and deserve. Please contact us to set up a free, no obligation case review to learn about your legal options.
Start Your Free Case Review
Give Us A Call
Our Experienced Lawyers
How can we help? Fill out the form for a free case review.
- Toll Free: 888.293.6883
May 23, 2019
RPWB Named To Leadership of 3M Combat Arms Ear Plug MDL
RPWB member attorney Elizabeth Middleton Burke was named to the leadership of the 3M Combat Arms Ear Plug multi-district litigation. Federal lawsuits filed against 3M for producing faulty military ear plugs have been consolidated in the Northern District of Florida. Burke was named as co-chair of the Plaintiff Steering Committee, which helps direct and manage […]READ MORE
May 20, 2019
Richardson is a Top 25 Lawyer (Again!)
RPWB Founding Member Terry Richardson has been named as one of the top 25 lawyers in South Carolina by Super Lawyers, one of the nation’s premiere attorney rating services. This marks Richardson’s ninth time appearing on the list. For three consecutive years, he was ranked as one of the top 10 attorneys in the state. […]READ MORE
Apr 24, 2019
RPWB named to leadership of firefighting foam MDL
CHARLESTON, S.C. – RPWB has been named to the leadership of litigation to help the nation’s water utilities filter out harmful chemicals left behind by firefighting foam manufactured by 3M and Tyco. RPWB member Christiaan Marcum sits on the Plaintiff Executive Committee of the Aqueous Film-Forming Foam (AFFF) Multi-District Litigation, which has been consolidated in […]READ MORE
Mar 25, 2019
Supreme Court ruling will help asbestos victims
By Dave Butler The United States Supreme Court delivered an unexpectedly good opinion for asbestos victims last week. For years, equipment makers (including those who make pumps, valves, turbines and boilers) have argued that they only make and sell metal products and cannot be held responsible for asbestos products made by third parties and later […]READ MORE
Jan 18, 2019
RPWB welcomes a new member
Richardson, Patrick, Westbrook & Brickman is proud to announce that Aaron Dias has been named the firm’s newest member. Dias has spent the entirety of his legal career with RPWB, beginning as a clerk during law school. In 2005, he became an associate attorney at the firm. His practice focuses primarily on pharmaceutical and other […]READ MORE
Dec 03, 2018
Parties agree to settle SC nuclear plant class action
SCANA and SCE&G settle class action lawsuit with Attorney General and Plaintiffs Related to V.C. Summer Nuclear Costs Plaintiffs Richard Lightsey, LeBrian Cleckley, and Phillip Cooper have reached an agreement with SCANA Corporation and South Carolina Electric & Gas Company to settle a lawsuit filed in the state Court of Common Pleas in Hampton County on […]READ MORE
Nov 02, 2018
RPWB is a 2019 U.S. News Best Law Firm
CHARLESTON, S.C. – Richardson, Patrick, Westbrook & Brickman was named a 2019 Best Law Firm by U.S. News & World Report, recognizing the plaintiff firm for its work on mass torts and class actions, product liability, securities, healthcare law, medical malpractice and personal injury lawsuits. With 16 lawyers listed on the underlying Best Lawyers in […]READ MORE
Oct 24, 2018
The Role of the Whistleblower: A look at qui tam litigation
By Chuck Dukes Qui tam litigation allows private citizens, like you, to join in the battle against government fraud. Every year, many of our public institutions—from the military to Medicare—are plagued by fraud. Astonishingly, it’s estimated that nearly 10% of all federal spending, or $350–$400B per year, is lost due to fraud. And by and […]READ MORE
Sep 18, 2018
Families of two smokers hooked by free samples awarded $113 million
The families of a pair of deceased smokers from the United States Virgin Islands were awarded $113 million by two juries last month. In a consolidated trial, the juries found that the maker of Newport cigarettes (previously Lorillard, now R.J. Reynolds) engaged in a program to hook young people, including children, on cigarettes. The program […]READ MORE
Aug 14, 2018
16 RPWB attorneys named to Best Lawyers List
CHARLESTON – Richardson, Patrick, Westbrook & Brickman was again recognized as South Carolina’s top-listed plaintiff law firm for product liability cases and mass tort/class actions by The Best Lawyers in America® in their 2019 edition released in August 2018. In all, 16 RPWB attorneys were named 2019 Best Lawyers, including four new additions to the […]READ MORE
Aug 14, 2018
Richardson on mass torts win: “Unrelenting pressure is essential.”
RPWB founding attorney Terry Richardson has worked on many mass tort cases throughout his four decades practicing law, but the 2005 Graniteville train crash stands out due to its size, scope and complexity. His experience with the case recently featured by the website drugwatcher.org in the article “11 of America’s Top Trial Lawyers Share Their […]READ MORE
Aug 14, 2018
RPWB accepting DePuy Elbow Implant cases
RPWB attorneys are representing patients who had to replace their faulty DePuy Synthes elbow implant, a defective medical device that was pulled from the market years ago yet it still causing problems. In late 2016, the DePuy Synthes elbow implant was recalled after people who received the devices reported problems with radial stem loosening at […]READ MORE
Aug 14, 2018
First three Abilify gambling cases settle
In April, the makers of Abilify settled the first three bellwether cases that were scheduled to go to trial this past June. Judge M. Casey Rodgers also ordered both sides to begin work on the framework for a global settlement for the nearly 2,000 other Abilify cases pending in the Northern District of Florida. The […]READ MORE
Aug 14, 2018
Wells Fargo Under Fire For 401(k) Rollover Practices
RPWB attorneys are investigating claims that Wells Fargo may have advised people rolling over their 401(k) retirement plans to invest in alternative investments in order to earn higher fees and commissions. These 401(k) rollovers have caught the attention of federal regulators with the Department of Justice, Department of Labor and the Securities Exchange Commission, who […]READ MORE
Apr 29, 2015
Richardson again named ‘Top 10 lawyer’ in SC
BARNWELL, SC – Founding RPWB member Terry E. Richardson, Jr. has been named one of South Carolina’s Top 10 attorneys by the national ranking service Super Lawyers for the second year in a row. The annual list highlights attorneys who have attained a high-degree of peer recognition and professional achievement. The selection process includes independent research, peer […]READ MORE